Prostate thermal therapy with catheter-based ultrasound devices and MR thermal monitoring

Will H. Nau; Chris J. Diederich; Adam Kinsey; Tony Ross; Jeff Wootton; Titania Juang; Kim Butts-Pauly; Viola Ricke; Erin H. Liu; Jing Chen; Donna M. Bouley; Maurice Van den Bosch; Graham Sommer M.D.

doi:10.1117/12.703184

9 February 2007 Prostate thermal therapy with catheter-based ultrasound devices and MR thermal monitoring

Will H. Nau, Chris J. Diederich, Adam Kinsey, Tony Ross, Jeff Wootton, Titania Juang, Kim Butts-Pauly, Viola Ricke, Erin H. Liu, Jing Chen, Donna M. Bouley, Maurice Van den Bosch, Graham Sommer M.D.

Author Affiliations +

Proceedings Volume 6440, Thermal Treatment of Tissue: Energy Delivery and Assessment IV; 64400D (2007) https://doi.org/10.1117/12.703184
Event: SPIE BiOS, 2007, San Jose, California, United States

Abstract

Four types of transurethral applicators were devised for thermal ablation of prostate combined with MR thermal monitoring: sectored tubular transducer devices with directional heating patterns; planar and curvilinear devices with narrow heating patterns; and multi-sectored tubular devices capable of dynamic angular control without applicator movement. These devices are integrated with a 4 mm delivery catheter, incorporate an inflatable cooling balloon (10 mm OD) for positioning within the prostate and capable of rotation via an MR-compatible motor. Interstitial devices (2.4 mm OD) have been developed for percutaneous implantation with directional or dynamic angular control. In vivo experiments in canine prostate under MR temperature imaging were used to evaluate the heating technology and develop treatment control strategies. MR thermal imaging in a 0.5 T interventional MRI was used to monitor temperature and thermal dose in multiple slices through the target volume. Sectored tubular, planar, and curvilinear transurethral devices produce directional coagulation zones, extending 15-20 mm radial distance to the outer prostate capsule. Sequential rotation and modulated dwell time can conform thermal ablation to selected regions. Multi-sectored transurethral applicators can dynamically control the angular heating profile and target large regions of the gland in short treatment times without applicator manipulation. Interstitial implants with directional devices can be used to effectively ablate the posterior peripheral zone of the gland while protecting the rectum. The MR derived 52 °C and lethal thermal dose contours (t₄₃=240 min) allowed for real-time control of the applicators and effectively defined the extent of thermal damage. Catheter-based ultrasound devices, combined with MR thermal monitoring, can produce relatively fast and precise thermal ablation of prostate, with potential for treatment of cancer or BPH.

Citation Download Citation

Will H. Nau, Chris J. Diederich, Adam Kinsey, Tony Ross, Jeff Wootton, Titania Juang, Kim Butts-Pauly, Viola Ricke, Erin H. Liu, Jing Chen, Donna M. Bouley, Maurice Van den Bosch, and Graham Sommer M.D. "Prostate thermal therapy with catheter-based ultrasound devices and MR thermal monitoring", Proc. SPIE 6440, Thermal Treatment of Tissue: Energy Delivery and Assessment IV, 64400D (9 February 2007); https://doi.org/10.1117/12.703184

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available